Camrelizumab After Completion of Radiotherapy for Oligometastatic Nasopharyngeal Carcinoma
Clinical trial NCT04221516 · UNKNOWN
Trial details
- NCT number
- NCT04221516
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2024-02-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.